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TO THE EDITOR
Atopic dermatitis (AD) is a complex
trait resulting from an interaction be-
tween a large variety of environmental
and genetic factors (Irvine and McLean,
2006; Rodrı´guez et al., 2009; van den
Oord and Sheikh, 2009). Research
on the filaggrin gene (FLG) in Asian
populations including Singapore has
confirmed that allelic variants in this
gene influence risk to AD (Akiyama,
2010), as in Europe, while also strength-
ening the evidence for other factors
involved in the disease etiology (Chen
et al., 2011). Recently, Sun et al. (2011)
reported a genome-wide association
study on AD in which they identified
two new susceptibility loci at 5q22.1
(rs7701890) and 20q13.33 (rs6010620),
and one suggestive locus at 10q21.2
(rs2393903) in the Chinese population.
The previously unreported associations
were validated in Northern and South-
ern Chinese, but only the 20q13.33
(rs6010620) locus was validated in a
German population, supporting the pre-
sence of ethnic differences or environ-
mental influences on the observed
genetic associations.
Here, we analyzed these three loci
in 827 AD cases and 1,104 controls
(Supplementary Information online),
all of which were Singaporean Chinese
(Andiappan et al., 2011). All three
single-nucleotide polymorphisms (SNPs)
were directly assayed by Taqman geno-
typing and were found to be in Hardy–
Weinberg equilibrium in controls
(P40.05). The chromosome (chr)10
and chr20 SNPs showed significant
association in our population (odds
ratio (OR)¼ 1.26 (95% confidence
interval (CI) 1.11–1.44), P¼0.0004;
and OR¼ 1.18 (95% CI 1.02–1.36),
P¼0.024, respectively). The effect sizes
of these associations are similar to that
reported in Sun et al. (Table 1). How-
ever, the chr5 SNP rs7701890 showed
no evidence of association (OR¼0.96
(95% CI 0.81–1.13), P¼0.59). With
our current sample size and the minor
allele frequency of 20% in Singaporean
Chinese, we estimate that we had close
to 80% power to detect the effect
observed by Sun et al. (OR 1.24; Purcell
et al., 2003).
The well-known association of atopy
with allergic phenotypes (Bousquet
et al., 2001, 2008) prompted us to
investigate the association of the three
SNPs with positive skin prick test (SPT)
results in our cohort. We analyzed
a total of 2,627 SPT-positive and
389 SPT-negative individuals, which
included both AD cases and controls.
There was no association with positive
SPT status (Supplementary Table S1
online), and adjustment for this SPT
status had little or no impact on the
AD association results for the chr10 and
chr20 SNPs. We then tested the three
above-mentioned SNPs (rs7701890,
rs2393903, and rs6010620) for associa-
tion with allergic rhinitis (AR; 472
cases) and asthma (323 cases), in the
absence of AD. The rs6010620 SNP
on 20q13.33 was associated with AR
(P¼0.008), although further validation
of this result is required. Although
the 5q22.1 locus has recently been
reported to be associated with AR
(Ramasamy et al., 2011), the SNP we
tested was not in linkage disequilibrium
with any of the reported SNPs (r2¼ 0
with rs17513503 and rs1898671).
The AD cases were separated into
two groups (i) AD only and (ii) AD with
other associated atopic conditions
(asthma, AR, or both). We found the
risk C allele of the chr10 locus showed
a significantly stronger association
with the group with AD only compared
with the group with AD and other
atopic conditions (OR¼ 1.45 (95% CI
1.21–1.79) vs 1.19 (1.03–1.38), P¼
0.038; Table 1). We then performed a
quantitative trait analysis in a subset of
397 AD cases whose disease seve-
rities were determined by the SCORing
Atopic Dermatitis (SCORAD) index
(Oranje et al., 2007). Consistently, we
found the CC genotype of rs2393903
at chr10 was significantly associated
with a lower SCORAD score (mean
33.99±1.568; n¼94), compared with
Abbreviations: AD, atopic dermatitis; AR, allergic rhinitis; CI, confidence interval; OR, odds ratio;
SCORAD, SCORing Atopic Dermatitis; SNP, single-nucleotide polymorphism; SPT, skin prick test
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the CT (mean 39.48±1.043, n¼197;
t-test P¼0.0034) or TT genotypes (mean
40.66±1.491, n¼98; t-test P¼0.0023;
Table 1 and Figure 1). Our findings
suggest that the chr10 risk allele is
associated with a milder form of AD,
whereas the chr20 SNP (rs6010620)
showed no effect on AD severity.
We also analyzed effects of these
three SNPs on serum measurements of
total IgE and specific IgE to Blomia
tropicalis and Dermatophagoides pter-
onyssinus mites in a subset of 151
individuals from the genotyped cohort.
The difference in the level of specific
IgE towards Blomia tropicalis was
observed among different genotype
groups of rs2393903 (P¼0.014), but
did not survive correction for multiple
testing (Supplementary Table S2 online
and Supplementary Figure S1 online).
To test whether the lack of asso-
ciation on chr5 in our Singaporean
Chinese AD samples could be attri-
buted to interaction with environmental
factors, we conducted gene–environ-
ment interaction analysis using a logis-
tic regression model in a subset of
our samples (up to 432 cases and 700
controls) for which data on alcohol
consumption, smoking and/or smoking
in subject’s presence, father’s and
mother’s education level, and household
income were available. We observed a
significant interaction with household
income (P¼0.017), in which the minor
allele G showed a risk effect (OR¼1.22
(95% CI 0.92–1.61), P¼0.17) in the
low-income group (o$4,000 a month)
but a protective effect (OR¼0.71 (95%
CI 0.49–1.01), P¼0.06) in high-income
group (4$4,000 a month; Supple-
mentary Table S3 online). In previous
studies prevalence of allergic diseases
has generally been shown to vary with
income level, with reduced prevalence
in lower income groups in Singapore
(Goh et al., 1996) and Hong Kong (Lau
et al., 1995), but increased prevalence
with lower income in countries like the
United States (Hanifin and Reed, 2007).
Environmental factors might therefore
be an important confounder, for which
income is potentially a surrogate marker
in our study. We speculate that this
may explain why our study did not
validate the Chinese finding on chr5, as
there is likely to be higher percentage
of subjects from a high-income envi-
ronment (38.9%) in the Singaporean
Chinese population compared with
the subjects of Chinese Han studied in
Sun et al. However, more extensive and
well-designed studies will be needed
to further dissect these interactions
between diseases, and social and envi-
ronmental factors.
Finally, having genotyped a subset
of our samples for FLG mutations (397
cases, 400 controls) and demonstrated
strong association with AD in these
samples (Chen et al., 2011), we per-
formed gene–gene interaction analyses
between the three SNPs and FLG-null
mutation carrier status. No evidence of
interaction was observed at any of the
Table 1. Association test results on the three SNPs with AD and AD severity
All AD AD only ADþ others
Association
with severity SCORAD
MAF
Power to detect
effect in
827 Cases,
1,104 controls
251 Cases,
1,104 controls
572 Cases,
1,104 controls
251 AD only,
572 ADþ others n=397
Chr SNP controls Sun et al. (2011)1 OR P-value OR P-value OR P-value P-value2 P-value3
5 rs7701890 0.20 (G) 79.0% 0.956 (0.809–1.129) 0.594 1.107 (0.870–1.416) 0.411 0.887 (0.732–1.073) 0.218 0.109 0.861
10 rs2393903 0.42 (C) 57.7% 1.264 (1.109–1.440) 0.0004 1.447 (1.210–1.791) 0.0002 1.190 (1.028–1.378) 0.021 0.038 0.003
20 rs6010620 0.28 (G) 60.7% 1.179 (1.022–1.360) 0.024 1.045 (0.842–1.303) 0.691 1.244 (1.061–1.459) 0.007 0.159 0.990
Abbreviations: AD, atopic dermatitis; Chr, chromosome; MAF, minor allele frequency; OR, odds ratio; SCORAD, SCORing Atopic Dermatitis;
SNP, single-nucleotide polymorphism.
1Genetic power calculator (a=0.05) based on current sample size and MAF in the controls.
2Comparing association with AD only versus AD+other atopic phenotypes (allergic rhinitis, asthma, or both).
3One-way analysis of variance (ANOVA) comparing SCORAD scores across the three genotype groups (Kolmogorov–Smirnov normality test P40.05).
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Figure 1. Distribution of SCORing Atopic Dermatitis (SCORAD) scores for atopic dermatitis (AD)
subjects (n¼ 397) grouped according to their genotypes at rs7701890 (chromosome (chr)5), rs2393903
(chr10), and rs6010620 (chr20). The solid line indicates the mean of each group. One-way analysis
of variance (ANOVA) test P-values comparing the three genotype groups, as well as Student’s t-test
P-values comparing the CC with CT and TT genotype groups at rs2393903 are shown.
1506 Journal of Investigative Dermatology (2012), Volume 132
AK Andiappan et al.
Validation of GWAS Loci
loci (P40.05; Supplementary Table S4
online), suggesting that these SNPs act
independently of FLG-null mutations
towards the contribution of atopic
disease. However, we note that our
power to detect interaction may be
limited by insufficient sample numbers
(Purcell et al., 2003).
In summary, our findings validate
a strong association at chr10q21.2 and
a weaker one at 20q13.33 with AD
among Singaporean Chinese subjects,
but suggests that genetic association at
5q22.1 might be influenced by the
interaction with environmental factors.
The identification of new validated AD
loci is important to further dissect the
genetic basis of this complex disease
and account for the large number of
AD cases that do not have FLG-null
mutations. Clinically this is also vital as
more genome-targeted therapies are
developed.
URLs
Genetic Power Calculator: http://pngu.
mgh.harvard.edu/~purcell/gpc/
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TO THE EDITOR
A key event during epidermal differen-
tiation is the proteolytic breakdown of
profilaggrin into ‘‘free’’ filaggrin mono-
mers. A recent study has shown that
the skin-specific retroviral-like aspartic
protease (SASPase) has a key role in
profilaggrin–filaggrin processing (Matsui
et al., 2011). SASPase cleaves the linker
peptide between the individual filag-
grin monomers of profilaggrin, and
on a hairless mouse background loss
of SASPase leads to dry, scaly skin with
reduced stratum corneum hydration
accompanied by accumulations of pro-
filaggrin–filaggrin intermediates but an
absence of filaggrin monomers (MatsuiAbbreviations: ASPRV1, SASPase gene; SASPase, skin-specific retroviral-like aspartic protease
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